70 related articles for article (PubMed ID: 2910485)
1. Progression of transplanted SJL/J lymphomas attributed to a single aggressive H-2Ds-negative lymphoma.
Sopchak L; King SR; Miller DA; Gabra N; Thrush GR; Lerman SP
Cancer Res; 1989 Feb; 49(3):665-71. PubMed ID: 2910485
[TBL] [Abstract][Full Text] [Related]
2. Aggressiveness of SJL/J lymphomas correlates with absence of H-2Ds antigens.
Rosloniec EF; Kuhn MH; Genyea CA; Reed AH; Jennings JJ; Giraldo AA; Beisel KW; Lerman SP
J Immunol; 1984 Feb; 132(2):945-52. PubMed ID: 6606680
[TBL] [Abstract][Full Text] [Related]
3. Loss of myb expression in an aggressive SJL/J B-cell lymphoma.
Sopchak L; Thrush GR; Lerman SP; King SR
Oncogene; 1991 Aug; 6(8):1335-8. PubMed ID: 1886709
[TBL] [Abstract][Full Text] [Related]
4. Clonality of lymphomas at multiple sites in SJL mice.
Tang JC; Ho FC; Chan AC; Srivastava G
Lab Invest; 1998 Feb; 78(2):205-12. PubMed ID: 9484718
[TBL] [Abstract][Full Text] [Related]
5. Progression of spontaneous lymphomas in SJL mice: monitoring in vivo clonal evolution with molecular markers in sequential splenic samples.
Tang JC; Ho FC; Chan AC; Chow EY; Srivastava G
Lab Invest; 1998 Nov; 78(11):1459-66. PubMed ID: 9840620
[TBL] [Abstract][Full Text] [Related]
6. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
Griesser DH
Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
[TBL] [Abstract][Full Text] [Related]
7. Progressive loss Of H-2Ds antigens during passage of a spontaneous SJL/J lymphoma.
Beisel KW; Lerman SP
Transplant Proc; 1981 Dec; 13(4):1811-3. PubMed ID: 7330968
[No Abstract] [Full Text] [Related]
8. Analysis of Ly-1+ B-cell populations and IgH rearrangements in "normal" spleens and in lymphomas of AKR/J and AKR Fv-1b mice.
Rosner A; Peled A; Haran-Ghera N; Canaani E
Cancer Res; 1993 May; 53(9):2147-53. PubMed ID: 7683252
[TBL] [Abstract][Full Text] [Related]
9. Inappropriate alloantigen-like specificities detected on reticulum cell sarcomas of SJL/J mice: characterization and biologic role.
Bonavida B; Roman JM; Hutchinson IV
Transplant Proc; 1980 Mar; 12(1):59-64. PubMed ID: 6154360
[TBL] [Abstract][Full Text] [Related]
10. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
[TBL] [Abstract][Full Text] [Related]
11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
12. Selective loss of H-2Ds antigen on a murine B lymphoma due to a post-transcriptional block in expression.
Luo H; Sopchak L; Lerman SP; King SR
Mol Immunol; 1995 Oct; 32(14-15):1011-20. PubMed ID: 8544850
[TBL] [Abstract][Full Text] [Related]
13. Molecular evidence that SJL reticulum cell sarcomas are derived from pre-B cell. Clonal rearrangement of heavy chain but not of light chain immunoglobulin genes.
Nakauchi H; Osada H; Yagita H; Okumura K
J Immunol; 1987 Oct; 139(8):2803-9. PubMed ID: 3116094
[TBL] [Abstract][Full Text] [Related]
14. IL-10 production in a CD5+ B cell lymphoma arising in a CD4 monoclonal antibody-treated SJL mouse.
Lin TZ; Fernandes H; Yauch R; Ponzio NM; Raveche E
Clin Immunol Immunopathol; 1992 Oct; 65(1):10-22. PubMed ID: 1382908
[TBL] [Abstract][Full Text] [Related]
15. The rat Nb2 lymphoma: a novel model for tumor progression.
Gout PW; Horsman DE; Fox K; De Jong G; Ma S; Bruchovsky N
Anticancer Res; 1994; 14(6B):2485-92. PubMed ID: 7872671
[TBL] [Abstract][Full Text] [Related]
16. Correlations between immunological phenotype and karyotype in malignant lymphoma.
Levine EG; Arthur DC; Gajl-Peczalska KJ; LeBien TW; Peterson BA; Hurd DD; Bloomfield CD
Cancer Res; 1986 Dec; 46(12 Pt 1):6481-8. PubMed ID: 3096564
[TBL] [Abstract][Full Text] [Related]
17. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
Lasky JL; Ponzio NM; Thorbecke GJ
J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
[TBL] [Abstract][Full Text] [Related]
18. Transformation in lymphomas--morphological, immunophenotypic and molecular features.
Prochorec-Sobieszek M; Majewski M; Sikorska A; Centkowski P; Tajer J; Lampka-Wojciechowska E; Rymkiewicz G; Konopka L; Meder J; Warzocha K; Maryniak RK
Pol J Pathol; 2006; 57(2):63-70. PubMed ID: 17019967
[TBL] [Abstract][Full Text] [Related]
19. SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells.
Sprangers M; Feldhahn N; Liedtke S; Jumaa H; Siebert R; Müschen M
Oncogene; 2006 Aug; 25(37):5180-6. PubMed ID: 16636677
[TBL] [Abstract][Full Text] [Related]
20. Oncogenesis by Moloney murine leukemia virus.
Tsichlis PN
Anticancer Res; 1987; 7(2):171-80. PubMed ID: 3592629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
